BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Allergan PLC (“Allergan” or the “Company”) (NYSE: AGN) securities between February 25, 2014 and November 3, 2016, inclusive (the “Class Period”). Allergan investors have until January 3, 2017 to file a lead plaintiff motion.
Investors suffering losses on their Allergan investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to firstname.lastname@example.org.
According to the Complaint filed in this lawsuit, Allergan made false and/or misleading statements and/or failed to disclose that: the Company and Actavis (an Allergan subsidiary) engaged in conduct that would result in a Department of Justice (“DOJ”) antitrust investigation; that the DOJ investigation and the underlying conduct could cause U.S. prosecutors to file criminal charges against the Company by the end of 2016 for suspected price collusion; that Allergan and Actavis lacked effective internal controls; and that as a result of the above, Allergan’s and Actavis’ public statements were materially false and misleading at all relevant times.
If you purchased shares of Allergan during the Class Period you may move the Court no later than January 3, 2017 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.